Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF NEUROLOGY   2016 , Volume 15 , Number 3; Page(s) 180 To 181.
 
Paper: 

FOLLOW-UP OF HYPERTENSION IN PATIENTS WITH MULTIPLE SCLEROSIS

 
 
Author(s):  BAGHBANIAN SEYED MOHAMMAD*
 
* DEPARTMENT OF NEUROLOGY, SCHOOL OF MEDICINE, BOOALISINA HOSPITAL, MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, SARI, IRAN
 
Abstract: 

The prevalence of hypertension is estimated over 10% in the multiple sclerosis (MS) population and increases with age. In some studies comparing the prevalence of hypertension in the MS population with a comparator, hypertension was reported more commonly among these patients. Only one cohort study reported the incidence of hypertension over a maximum follow-up of 30 years as 3.73% in patients with MS. Sometimes, new-onset hypertension could be a presenting sign of an adverse event. Transient hypertension may be an adverse event of intravenous methylprednisolone. Hypotension, a known adverse effect of interferon (INF), is a known risk factor of ischemic colitis and ischemic colitis is one of the serious adverse events of treatment with IFNs type I. Ischemic colitis should be considered in INF and acetylcholine inhibitors (AChI) and calcium channel blockers (CCB) co-administration.

 
Keyword(s): MULTIPLE SCLEROSIS, HYPERTENSION, FOLLOW-UP
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 70
 
Latest on Blog
Enter SID Blog